Project Grant HT94252310721
- The Department of the Army Medical Command awarded a $539,979 project grant to Imperial College London under the Military Medical Research and Development program. The grant will fund research from August 2021 to August 2024 to develop a monoclonal antibody targeting CXCL13 to promote axonal plasticity, regeneration, and functional recovery after spinal cord injury. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
- This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...
- The federal Project Grant award of $1,576,368 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) will fund an evaluation of electrical stimulation during nerve transfer surgery for cervical spinal cord injury at Stanford University. The grant, awarded on August 1, 2024, with a completion date of July 31, 2027, will support innovative research to develop advanced medical treatments for this condition. As a leading research institution,...
- The U.S. Defense Health Agency awarded King's College London a $1,712,517 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to identify molecular predictors of risk and validate the evolution of ductal carcinoma in situ (DCIS) over a 4-year period ending on September 29, 2027. As the prime awardee, King's College London will leverage its expertise in biomedical research to advance the scientific understanding of breast cancer progression. This award supports...
- The University of British Columbia (UBC) received a $1,731,421.95 Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) to provide advanced physiologic monitoring at the site of spinal cord injury. The 3-year project, with a start date of September 30, 2023, will focus on transforming healthcare for Service Members and the public through innovative and impactful research into medical solutions for the battlefield. As the...
- This Project Grant award of $568,114.00 from the Defense Health Agency was made to Ecole Polytechnique Fédérale De Lausanne (EPFL), a university in Lausanne, Switzerland, to conduct research and development related to baroprosthesis to reduce secondary damage of traumatic spinal cord injury. The award was made under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members and the public. The research...
- The University of British Columbia was awarded a $1,868,800 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) with a performance period of September 1, 2025 to August 31, 2028. The grant will fund research on the effect of cardiocentric hemodynamic management on cardiovascular outcomes in individuals with acute cervical spinal cord injuries. This project aims to develop novel diagnostic tools, therapeutic interventions, and clinical...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...
- The Department of the Army Medical Command awarded a $711,403 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) under the Military Medical Research and Development program (CFDA 12.420). The grant supports a project titled "A Noninvasive Neurotrophic Factor Treatment to Repair the Injured Spinal Cord" with a period of performance from October 1, 2024 to September 30, 2027. This project grant supports advanced biomedical research focused...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $746,972.00 to Texas A&M University to conduct research on "PROTECTING THE INJURED SPINAL CORD: MODULATING AUTONOMIC FUNCTION AFTER SPINAL CORD INJURY (SCI) TO REDUCE TISSUE LOSS AND IMPROVE NEUROLOGICAL OUTCOME". The research seeks to develop new treatments to improve outcomes for individuals with spinal cord injuries by investigating...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $506,232.00 to Imperial College of Science, Technology and Medicine (doing business as Imperial College London) to investigate the repair ability and mechanisms of combinatorial pharmacological and biomaterial-based interventions after experimental spinal cord injury. The award, which begins on Sep 15, 2023 and is scheduled to be completed by Sep 14, 2026, will fund cutting-edge biomedical research aimed at transforming healthcare for Service Members and the public through innovative and impactful spinal cord injury treatments. Imperial College London, a world-class university with an extensive history of federal contract and grant awards, will lead this multi-year research project.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $506.2k | 9/11/23 |